Showing results (1601-1610 of 45,222) with videos related to
Sort By:
Pageof 4,523
Cancer Research|April 1, 1985
Phase I and clinical pharmacological study of mercaptopurine administered as a prolonged intravenous infusionS Zimm, L J Ettinger, J S Holcenberg, et al.Cancer Research|May 1, 1985
Extraction of a murine tumor-specific antigen from cells and plasma membranes using 1-butanol: augmentation of antigen yield by colchicineS J LeGrue, B D KahanCancer Research|March 1, 1978
Formation of a mutagenic drug metabolite by intestinal microorganismsR P Batzinger, E Bueding, B S Reddy, et al.Cancer Research|August 1, 1984
Inhibitory activity on murine granulocytic colony formation of bone marrow cell-conditioned medium obtained from colony-stimulating factor-producing tumor-bearing nude miceK Motoyoshi, Y Ishizaka, K Ikeda, et al.Cancer Research|September 1, 1984
Inhibition of dimethyl sulfoxide-induced differentiation of Friend erythroleukemic cells by 5'-methylthioadenosineP P Di Fiore, M Grieco, A Pinto, et al.Cancer Research|December 1, 1983
Immunohistochemical study with monoclonal antibodies on immune response in human lung cancersS Watanabe, Y Sato, T Kodama, et al.Cancer Research|February 1, 1984
Clonal growth of human acute myeloid leukemia cells (ML-1 and HL-60) in serum-free agar mediumF Taketazu, K Kubota, S Kajigaya, et al.Cancer Research|March 1, 1984
Augmentation of natural killer cell activity by lipopolysaccharide through separable effects on the binding of nonadherent lymphocytes to tumor targets and tumor killingR A Salata, M E Kleinhenz, B Z Schacter, et al.Cancer Research|April 1, 1984
Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapyE V Genovesi, C L Pettey, J J CollinsCancer Research|April 1, 1984
Reduced trisialoganglioside synthesis in chemically but not mos-transformed mouse epidermal cellsL Srinivas, N H ColburnPageof 4,523